Hemolytic-Uremic Syndrome
|
0.400 |
Biomarker
|
disease |
MGD |
|
|
|
Hemolytic-Uremic Syndrome
|
0.400 |
Biomarker
|
disease |
HPO |
|
|
|
Hemolytic-Uremic Syndrome
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Two brothers and one sister had three variants of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome (the 'TTP-HUS' complex).
|
3389894 |
1988 |
Hemolytic-Uremic Syndrome
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Escherichia coli O157:H7, a Shiga-like toxin (SLT)-producing enteric pathogen, has been implicated in most cases of post-diarrheal hemolytic uremic syndrome (D + HUS).
|
9260252 |
1997 |
Hemolytic-Uremic Syndrome
|
0.400 |
Biomarker
|
disease |
BEFREE |
These observations suggest a role for FH and/or FH receptors in the pathogenesis of idiopathic HUS.
|
9848786 |
1998 |
Hemolytic-Uremic Syndrome
|
0.400 |
Biomarker
|
disease |
BEFREE |
In light of these findings and previous reports of HUS in patients with factor H deficiency, we postulate that abnormalities of factor H may be involved in the etiology of HUS.
|
9551389 |
1998 |
Hemolytic-Uremic Syndrome
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Hypocomplementemic autosomal recessive hemolytic uremic syndrome with decreased factor H.
|
9811382 |
1998 |
Hemolytic-Uremic Syndrome
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
We examined the possibility of an association between the bacterial genotype of Escherichia coli O157:H7 and the likelihood of progression to neurological complications in childhood gastroenteritis-associated haemolytic uraemic syndrome (D+HUS).
|
9641746 |
1998 |
Hemolytic-Uremic Syndrome
|
0.400 |
Biomarker
|
disease |
BEFREE |
Reduced C3 clusters in familial HUS and TTP is likely related to a genetically determined deficiency in factor H and may predispose to the disease.
|
10215327 |
1999 |
Hemolytic-Uremic Syndrome
|
0.400 |
Biomarker
|
disease |
BEFREE |
These findings represent further evidence of the association between factor H dysfunction and HUS.
|
10344366 |
1999 |
Hemolytic-Uremic Syndrome
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
A previous report demonstrated that a dominant form of HUS maps to chromosome 1q and that complement factor H (CFH), a regulatory component of the complement system, lies within the region and is involved in the dominant disorder.
|
10577907 |
1999 |
Hemolytic-Uremic Syndrome
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
These data provide compelling molecular evidence that genetically determined deficiencies in factor H are involved in both autosomal-dominant and autosomal-recessive hemolytic uremic syndrome and identify SCR20 as a hot spot for mutations in the disease.
|
11158219 |
2001 |
Hemolytic-Uremic Syndrome
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
To identify the relative importance of mutations in FH as a cause of HUS, we have undertaken mutation screening of the FH gene in 19 familial and 31 sporadic patients with FH.
|
11170896 |
2001 |
Hemolytic-Uremic Syndrome
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Hemolytic uremic syndrome: how do factor H mutants mediate endothelial damage?
|
11429311 |
2001 |
Hemolytic-Uremic Syndrome
|
0.400 |
Biomarker
|
disease |
BEFREE |
In this review, we summarize recent genetic and biochemical data, which indicate a critical role for factor H in the pathogenesis of HUS and suggest an important role of the most C-terminal domain, i.e.SCR 20, in the disease.
|
11367530 |
2001 |
Hemolytic-Uremic Syndrome
|
0.400 |
Biomarker
|
disease |
BEFREE |
Molecular modelling of the C-terminal domains of factor H of human complement: a correlation between haemolytic uraemic syndrome and a predicted heparin binding site.
|
11851332 |
2002 |
Hemolytic-Uremic Syndrome
|
0.400 |
GeneticVariation
|
disease |
LHGDN |
Genetic studies have demonstrated the involvement of the complement regulator factor H in nondiarrheal, nonverocytotoxin (i.e., atypical) cases of hemolytic uremic syndrome.
|
12424708 |
2002 |
Hemolytic-Uremic Syndrome
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
These particular domains are conserved in all FHRs identified so far, include contact points for C3b, heparin and microbial surface proteins and represent a 'hot-spot' for gene mutations in patients that suffer from the Factor H-associated form of haemolytic uraemic syndrome.
|
12440956 |
2002 |
Hemolytic-Uremic Syndrome
|
0.400 |
Biomarker
|
disease |
BEFREE |
Cutting edge: localization of the host recognition functions of complement factor H at the carboxyl-terminal: implications for hemolytic uremic syndrome.
|
12391176 |
2002 |
Hemolytic-Uremic Syndrome
|
0.400 |
Biomarker
|
disease |
BEFREE |
These data demonstrate that single amino acid exchanges of two nonframework amino acids either alone or in combination block protein secretion of factor H. This observation is also of interest for other human diseases in which factor H is involved, such as human factor H-associated form of hemolytic uremic syndrome.
|
12466119 |
2002 |
Hemolytic-Uremic Syndrome
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
We did a simultaneous kidney and liver transplantation in a 2-year-old child with HUS and a mutation in complement factor H to restore the defective factor H, with no recurrence of the disease.
|
12020532 |
2002 |
Hemolytic-Uremic Syndrome
|
0.400 |
Biomarker
|
disease |
BEFREE |
Genetic studies have demonstrated the involvement of the complement regulator factor H in nondiarrheal, nonverocytotoxin (i.e., atypical) cases of hemolytic uremic syndrome.
|
12424708 |
2002 |
Hemolytic-Uremic Syndrome
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Mutations in factor H, a fluid-phase regulator of the alternative complement pathway, have been identified in 10-20% of patients with both familial and sporadic (non-diarrhoeal-associated) haemolytic uraemic syndrome.
|
12105394 |
2002 |
Hemolytic-Uremic Syndrome
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Factor H mutations occur in 10-20% of patients with hemolytic uremic syndrome (HUS).
|
14566051 |
2003 |
Hemolytic-Uremic Syndrome
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Of 7 patients with HUS associated with normal factor H concentration but mutations in factor H gene who were transplanted, probably 2 had recurrence.
|
13680331 |
2003 |